Netherlands (NL)

Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, et al. Journal article Can a Clinical Examination Demonstrate Intramuscular Tendon Involvement in Acute Hamstring Injuries? (2017) Crema MD, Guermazi A, Reurink G, Roemer F, Maas M, Weir A, Moen MH, et al. Journal article Definitions, measurement and prevalence of sedentary behaviour in adults with intellectual disabilities - A systematic review (2017) Melville CA, Oppewal A, Elinder LS, Freiberger E, Guerra-Balic M, Hilgenkamp TIM, Einarsson I, et al. Journal article, Review article BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer (2017) Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FMGR, et al. Journal article TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al. Journal article Comparison between clinical gait and daily-life gait assessments of fall risk in older people (2017) Brodie MA, Coppens MJ, Ejupi A, Gschwind YJ, Annegarn J, Schöne D, Wieching R, et al. Journal article The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain (2017) Armbruster A, Neumann E, Koetter V, Hermanns H, Werdehausen R, Eulenburg V Journal article Scale-dependent diffusion anisotropy in nanoporous silicon. (2017) Kondrashova D, Lauerer A, Mehlhorn D, Jobic H, Feldhoff A, Thommes M, Chakraborty D, et al. Journal article, Original article Salt Sensitivity of Angiogenesis Inhibition-Induced Blood Pressure Rise: Role of Interstitial Sodium Accumulation? (2017) Lankhorst S, Severs D, Marko L, Rakova N, Titze J, Mueller DN, Danser AHJ, Van Den Meiracker AH Journal article STRUCTURAL DAMAGE PROGRESSION IN PATIENTS TREATED WITH METHOTREXATE, BARICITINIB MONOTHERAPY OR BARICITINIB plus METHOTREXATE BASED ON THEIR LEVEL OF CLINICAL RESPONSE IN THE PHASE 3 RA-BEGIN STUDY (2017) Van Der Heijde D, Durez P, Schett G, Naredo E, Ostergaard M, Meszaros G, Bello N, et al. Conference contribution